rs1262933856
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_153717.3(EVC):c.1777-1G>A variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.0000103 in 1,551,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/2 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_153717.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVC | ENST00000264956.11 | c.1777-1G>A | splice_acceptor_variant, intron_variant | Intron 12 of 20 | 1 | NM_153717.3 | ENSP00000264956.6 | |||
EVC | ENST00000506240.1 | n.94G>A | non_coding_transcript_exon_variant | Exon 1 of 2 | 3 | |||||
CRMP1 | ENST00000506216.5 | n.1647+31887C>T | intron_variant | Intron 12 of 12 | 5 | |||||
EVC | ENST00000515113.1 | n.-1G>A | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000640 AC: 1AN: 156352Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 82332
GnomAD4 exome AF: 0.0000107 AC: 15AN: 1399386Hom.: 0 Cov.: 30 AF XY: 0.00000724 AC XY: 5AN XY: 690270
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74352
ClinVar
Submissions by phenotype
Ellis-van Creveld syndrome Pathogenic:3
Variant summary: EVC c.1777-1G>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Three predict the variant abolishes a 3' acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 6.4e-06 in 156352 control chromosomes (gnomAD). c.1777-1G>A has been reported in the literature in the compound heterozygous state in an individual affected with Ellis-van Creveld syndrome (D'Asdia_2013). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 23220543). ClinVar contains an entry for this variant (Variation ID: 554484). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
ACMG classification criteria: PVS1 strong, PS4 supporting, PM2 moderate, PM3 supporting -
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Pathogenic:2
This sequence change affects an acceptor splice site in intron 12 of the EVC gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in EVC are known to be pathogenic (PMID: 23220543). This variant is present in population databases (no rsID available, gnomAD 0.002%). Disruption of this splice site has been observed in individuals with Ellis-van Creveld syndrome (PMID: 17024374, 23220543). ClinVar contains an entry for this variant (Variation ID: 554484). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at